Mauro Rongioletti Selected Research

Ceruloplasmin (Ferroxidase)

1/2020	Iron Serum Markers Profile in Frontotemporal Lobar Degeneration.
1/2018	Serum Copper is not Altered in Frontotemporal Lobar Degeneration.
1/2018	Copper dyshomeostasis in Wilson disease and Alzheimer's disease as shown by serum and urine copper indicators.
1/2018	Prognostic Value of Serum Copper for Post-Stroke Clinical Recovery: A Pilot Study.
1/2017	Non-Ceruloplasmin Copper Distincts Subtypes in Alzheimer's Disease: a Genetic Study of ATP7B Frequency.
1/2017	Erratum to: Non-Ceruloplasmin Copper Distincts Subtypes in Alzheimer's Disease: a Genetic Study of ATP7B Frequency.
1/2017	Patients with Increased Non-Ceruloplasmin Copper Appear a Distinct Sub-Group of Alzheimer's Disease: A Neuroimaging Study.
1/2016	Non-Ceruloplasmin Copper Distinguishes A Distinct Subtype of Alzheimer's Disease: A Study of EEG-Derived Brain Activity.
1/2016	Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mauro Rongioletti Research Topics

Disease

12	Alzheimer Disease (Alzheimer's Disease) 03/2022 - 01/2016
2	COVID-19 02/2022 - 08/2021
2	Dementia (Dementias) 01/2021 - 01/2018
2	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2020 - 01/2018
2	Inflammation (Inflammations) 01/2019 - 03/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2022
1	Neoplasms (Cancer) 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Macular Degeneration (Age-Related Maculopathy) 01/2019
1	Retinal Diseases 01/2019
1	Hepatolenticular Degeneration (Wilson's Disease) 01/2018
1	Stroke (Strokes) 01/2018
1	Ischemic Stroke 01/2018
1	Atrophy 01/2017
1	Hypersensitivity (Allergy) 03/2014
1	Asthma (Bronchial Asthma) 03/2014
1	Homocysteinemia 05/2005
1	Ovarian Neoplasms (Ovarian Cancer) 05/2005
1	Hyperhomocysteinemia 05/2005

Drug/Important Bio-Agent (IBA)

15	CopperIBA 03/2022 - 01/2016
9	Ceruloplasmin (Ferroxidase)IBA 01/2020 - 01/2016
2	ZincIBA 02/2022 - 08/2021
2	AntioxidantsIBA 08/2021 - 01/2018
2	Transferrin (beta 2 Transferrin)IBA 01/2020 - 01/2018
2	IronIBA 01/2020 - 01/2018
2	Ferritins (Ferritin)IBA 01/2020 - 01/2018
2	Amyloid (Amyloid Fibrils)IBA 01/2019 - 01/2017
1	MicroRNAs (MicroRNA)IBA 03/2022
1	Hemostatics (Antihemorrhagics)IBA 02/2022
1	Free RadicalsIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	RadiopharmaceuticalsIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 08/2021
1	MicronutrientsIBA 08/2021
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	gamma-Aminobutyric Acid (GABA)IBA 01/2020
1	Genetic Markers (Genetic Marker)IBA 01/2020
1	MetalsIBA 01/2018
1	PeroxidesIBA 01/2018
1	Apolipoprotein E4IBA 01/2017
1	IonsIBA 01/2017
1	tau Proteins (tau Protein)IBA 01/2017
1	O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfateIBA 03/2014
1	EnzymesIBA 03/2014
1	Glutathione Transferase (Glutathione S-Transferase)IBA 03/2014
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 05/2005
1	SelectinsIBA 05/2005
1	Methotrexate (Mexate)FDA LinkGeneric 05/2005

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2022
1	Therapeutics 01/2022
1	Aftercare (After-Treatment) 05/2005